Mohamed El-Tantawy Ibrahim, Eman El Bana and Hanan I El-Kerdasy
Benha University, Egypt
Posters & Accepted Abstracts: J Nephrol Ther
Background: Cisplatin is a highly effective antitumor agent whose clinical application is limited by its nephrotoxicity which is associated with high mortality and morbidity rates. We aimed to study the protective role of silymarin and mesenchymal stem cells as a therapeutic tool of cisplatin nephrotoxicity. Methods: We injected the rats with cisplatin in a dose of 5 mg/kg BW for five days to induced acute renal failure (ARF). Silymarin was administrated 6 hours before cisplatin injection and mesenchymal stem cells were injected 24 hours after cisplatin induced ARF. Results: We assessed the ARF biochemically by elevation of kidney function tests and histopathologically by an alteration of the histological architecture of the renal cortex in form of shrinkage of glomeruli, lobulated tufts and glomerular hypertrophy with narrowing capsular space. The tubules showed extensive tubular degeneration with cellular hyaline materials and debris in the lumen of the renal tubules. The renal blood vessels appeared sclerotic with marked thickened walls. When silymarin was given in different doses before cisplatin, it decreased the toxic effect of cisplatin in the kidney but sclerotic blood vessels remained. Injection of mesenchymal stem cells in rats with ARF induced by cisplatin improved the histopathological effects of cisplatin in renal tissues and kidney function tests were significantly improved. Conclusions: There was a significant improvement in kidney function tests and renal histopathology by using silymarin as protective mechanism in cisplatin-induced ARF and mesenchymal stem cells administration denoted more remarkable therapeutic effect in ARF. tantawy_d@yahoo.com
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 